Pharmacogenomics: A Primer for Clinicians
Step 1. Download Adobe Digital Editions Both PC and Mac users will need to download Adobe Digital Editions to access their eBook. You can download Adobe Digital Editions at Adobe's website here.
Step 2. Register an Adobe ID if you do not already have one. (This step is optional, but allows you to open the file on multiple devices) Visit account.Adobe.com to register your Adobe account.
Step 3: Authorize Adobe Digital Editions using your Adobe ID. In Adobe Digital Editions, go to the Help menu. Choose “Authorize Computer.”
Step 4: Open your file with Adobe Digital Editions. Once you’ve linked your Adobe Digital Editions with your Adobe ID, you should be able to access your eBook on any device which supports Adobe Digital Editions and is authorized with your ID. If your eBook does not open in Adobe Digital Editions upon download, please contact customer service
- Preface
- 1. Introduction and Fundamentals of Pharmacogenomics
- 2 Implementation: A Guide to Implementing Pharmacogenomics Services
- 3 Ethical, Legal, and Social Issues in Pharmacogenomics
- 4 Pharmacogenomics Resources
- 5 Cardiology Pharmacogenomics
- 6 Infectious Diseases Pharmacogenomics
- 7 Oncology Pharmacogenomics
- 8 Psychiatry and Neurology Pharmacogenomics
- 9 Transplant Pharmacogenomics
- Index
An invaluable resource to the rapidly emerging field of pharmacogenomics—complete with case studies, clinical pearls, and treatment recommendations
The aim of pharmacogenomics is to improve personalized medicine by taking into account how genes affect an individual’s tolerability and response to drugs. Approaching pharmacogenomics from the current clinical, scientific, and implementation perspectives, this guide serves as an invaluable evidence-based resource to the subject. Reflecting the shift from genetics to genomics in the pharmaceutical sphere, the book covers pharmacogenomics fundamentals; genotyping tests and evidence; clinical implementation; ethical, legal, and social issues; and more. You’ll also find illuminating case scenarios, clinical pearls, and evidence-based recommendations for treatments and alternatives based on CPIC, PharmGKB, and FDA guidelines.